VERICEL CORPORATION Increase (Decrease) in Accounts Payable
VERICEL CORPORATION (VCEL) reported Increase (Decrease) in Accounts Payable of $4.16 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-07-30
- VERICEL CORPORATION increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $1.57M, a 19537.50% increase year-over-year.
- VERICEL CORPORATION increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $2.59M.
- VERICEL CORPORATION increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $713.00K, a 47.26% decline year-over-year.
- VERICEL CORPORATION increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $2.80M.
- VERICEL CORPORATION increase (decrease) in accounts payable for fiscal 2025 was $2.97M.
- VERICEL CORPORATION increase (decrease) in accounts payable for fiscal 2024 was -$287.00K, a 109.41% decline from fiscal 2023.
- VERICEL CORPORATION increase (decrease) in accounts payable for fiscal 2023 was $3.05M, a 112.18% increase from fiscal 2022.
- VERICEL CORPORATION increase (decrease) in accounts payable for fiscal 2022 was $1.44M, a 3.62% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $4.16M 10-Q · filed 2026-07-30 | $4.87M derived: sum of 3 quarters · filed 2026-07-30 | $7.68M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $2.59M 10-Q · filed 2026-05-07 | $3.30M derived: sum of 2 quarters · filed 2026-05-07 | $6.11M derived: sum of 3 quarters · filed 2026-05-07 | $6.12M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $713.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.52M derived: sum of 2 quarters · filed 2026-02-26 | $3.52M derived: sum of 3 quarters · filed 2026-07-30 | $2.97M 10-K · filed 2026-02-26 |
| 2025-09-30 | $2.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.81M derived: sum of 2 quarters · filed 2026-07-30 | $2.26M 10-Q · filed 2025-11-06 | $3.61M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$543.00K 10-Q · filed 2026-07-30 | $809.00K derived: sum of 3 quarters · filed 2026-07-30 | -$621.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | -$551.00K 10-Q · filed 2026-05-07 | $801.00K derived: sum of 2 quarters · filed 2026-05-07 | -$629.00K derived: sum of 3 quarters · filed 2026-05-07 | $4.04M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$78.00K derived: sum of 2 quarters · filed 2026-02-26 | $4.60M derived: sum of 3 quarters · filed 2026-02-26 | -$287.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | -$1.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $3.24M derived: sum of 2 quarters · filed 2025-11-06 | -$1.64M 10-Q · filed 2025-11-06 | $1.05M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $4.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$209.00K 10-Q · filed 2025-07-31 | $2.48M derived: sum of 3 quarters · filed 2026-02-26 | $1.88M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$4.88M 10-Q · filed 2025-05-08 | -$2.19M derived: sum of 2 quarters · filed 2026-02-26 | -$2.79M derived: sum of 3 quarters · filed 2026-02-26 | -$1.56M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $2.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.09M derived: sum of 2 quarters · filed 2026-02-26 | $3.32M derived: sum of 3 quarters · filed 2026-02-26 | $3.05M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$596.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $634.00K derived: sum of 2 quarters · filed 2024-11-07 | $360.00K 10-Q · filed 2024-11-07 | $1.83M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $956.00K 10-Q · filed 2024-08-01 | $2.43M derived: sum of 3 quarters · filed 2025-02-27 | $1.24M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$274.00K 10-Q · filed 2024-05-08 | $1.20M derived: sum of 2 quarters · filed 2025-02-27 | $11.00K derived: sum of 3 quarters · filed 2025-02-27 | $1.38M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $285.00K derived: sum of 2 quarters · filed 2025-02-27 | $1.66M derived: sum of 3 quarters · filed 2025-02-27 | $1.44M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$1.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $182.00K derived: sum of 2 quarters · filed 2023-11-08 | -$37.00K 10-Q · filed 2023-11-08 | $2.13M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $1.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $1.15M 10-Q · filed 2023-08-02 | $3.31M derived: sum of 3 quarters · filed 2024-02-29 | $1.29M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$219.00K 10-Q · filed 2023-05-10 | $1.94M derived: sum of 2 quarters · filed 2024-02-29 | -$84.00K derived: sum of 3 quarters · filed 2024-02-29 | -$902.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $2.16M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $135.00K derived: sum of 2 quarters · filed 2024-02-29 | -$683.00K derived: sum of 3 quarters · filed 2024-02-29 | $1.49M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$2.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$2.85M derived: sum of 2 quarters · filed 2022-11-09 | -$672.00K 10-Q · filed 2022-11-09 | -$587.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | -$818.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $1.36M 10-Q · filed 2022-08-03 | $1.44M derived: sum of 3 quarters · filed 2023-02-23 | $3.08M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $2.17M 10-Q · filed 2022-05-04 | $2.26M derived: sum of 2 quarters · filed 2023-02-23 | $3.90M derived: sum of 3 quarters · filed 2023-02-23 | $2.27M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $1.73M derived: sum of 2 quarters · filed 2023-02-23 | $92.00K derived: sum of 3 quarters · filed 2023-02-23 | $33.00K 10-K · filed 2023-02-23 |
| 2020-09-30 | $1.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $7.00K derived: sum of 2 quarters · filed 2021-11-09 | -$52.00K 10-Q · filed 2021-11-09 | $819.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | -$1.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$1.69M 10-Q · filed 2021-08-04 | -$821.00K derived: sum of 3 quarters · filed 2022-02-24 | -$478.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | -$59.00K 10-Q · filed 2021-05-05 | $812.00K derived: sum of 2 quarters · filed 2022-02-24 | $1.16M derived: sum of 3 quarters · filed 2022-02-24 | $285.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $871.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $1.21M derived: sum of 2 quarters · filed 2022-02-24 | $344.00K derived: sum of 3 quarters · filed 2022-02-24 | -$1.02M 10-K · filed 2022-02-24 |
| 2019-09-30 | $343.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$527.00K derived: sum of 2 quarters · filed 2020-11-05 | -$1.90M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | -$870.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$2.24M 10-Q · filed 2020-08-05 | ||
| 2019-03-31 | -$1.37M 10-Q · filed 2020-05-11 | |||
| 2018-12-31 | $899.00K 10-K · filed 2021-02-24 | |||
| 2017-12-31 | -$1.36M 10-K · filed 2020-02-25 | |||
| 2016-12-31 | -$1.08M 10-K · filed 2019-02-26 | |||
| 2015-12-31 | $1.73M 10-K · filed 2018-03-05 | |||
| 2014-12-31 | $2.77M 10-K · filed 2017-03-13 | |||
| 2013-12-31 | -$571.00K 10-K · filed 2016-03-14 | |||
| 2012-12-31 | $284.00K 10-K · filed 2015-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |